These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 912199)

  • 1. On the structural requirements for dopamine-like activity in homogenates of rat nucleus accumbens [proceedings].
    Munday KA; Poat JA; Watling KJ; Woodruff GN
    Br J Pharmacol; 1977 Sep; 61(1):150P-151P. PubMed ID: 912199
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between cholinergic and dopaminergic mechanisms in the nucleus accumbens for the control of locomotor activity [proceedings].
    Costall B; Hui SC; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):121P-122P. PubMed ID: 454917
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of dopamine receptor agonists and antagonists in the rat nucleus acumbens [proceedings].
    Freedman SB; Wait CP; Woodruff GN
    Br J Pharmacol; 1979 Nov; 67(3):430P-431P. PubMed ID: 497555
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholecystokinin potentiates dopamine-mediated behaviors in the nucleus accumbens, a site of CCK-DA co-existence.
    Crawley JN
    Psychopharmacol Bull; 1985; 21(3):523-7. PubMed ID: 4034868
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic value of the coexistence of cholecystokinin and dopamine. Electrophysiological studies in the rat].
    Debonnel G; de Montigny C
    Encephale; 1989; 15 Spec No():157-63. PubMed ID: 2743936
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens.
    Vance MA; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
    van Ree JM; Igarashi J; Király I
    NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The nucleus accumbens: is it an exclusive component of the dopaminergic system of the basal ganglia?].
    Herrera-Marschitz M; Ungerstedt U
    Neurologia; 1987; 2(2):47-9. PubMed ID: 3274069
    [No Abstract]   [Full Text] [Related]  

  • 9. [Participation of the dopamine of the striatum and the nucleus accumbens in the formation of aggressive and submissive behaviors in mice].
    Kudriavtseva NN; Nikulina EM; Popova NK
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(6):1168-70. PubMed ID: 3245329
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens.
    Tassin JP; Simon H; Hervé D; Blanc G; Le Moal M; Glowinski J; Bockaert J
    Nature; 1982 Feb; 295(5851):696-8. PubMed ID: 6276780
    [No Abstract]   [Full Text] [Related]  

  • 11. Histamine: correlative studies in nucleus accumbens.
    Chronister RB; Palmer GC; Defrance JF; Sikes RW; Hubbard JI
    J Neurobiol; 1982 Jan; 13(1):23-37. PubMed ID: 6120210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of functional heterogeneity of rat forebrain dopamine-reactive structures].
    Iakimovskiĭ AF
    Fiziol Zh SSSR Im I M Sechenova; 1981 Sep; 67(9):1317-23. PubMed ID: 7297728
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of the globus pallidus (GP) and nucleus accumbens (NAc) in the control of avoidance conditioning of rats].
    Mei ZT; Li DQ
    Sheng Li Xue Bao; 1987 Jun; 39(3):220-6. PubMed ID: 3672138
    [No Abstract]   [Full Text] [Related]  

  • 15. Microiontophoretic studies of the dopaminergic inhibition from the ventral tegmental area to the nucleus accumbens neurons.
    Akaike A; Sasa M; Takaori S
    J Pharmacol Exp Ther; 1984 Jun; 229(3):859-64. PubMed ID: 6726660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of cholecystokinin: central dopaminergic systems.
    Wang RY; White FJ
    Prog Clin Biol Res; 1985; 192():95-103. PubMed ID: 4080721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
    Wray SR; Melville GN; Wenger T; Louden D
    West Indian Med J; 1984 Jun; 33(2):106-16. PubMed ID: 6541399
    [No Abstract]   [Full Text] [Related]  

  • 18. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ; Rankin J
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-sensitive adenylate cyclase in homogenates of rat nucleus accumbens: structure-activity studies and effects of agonists and antagonists.
    Watling KJ; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Jun; 56(1-2):45-9. PubMed ID: 38129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alimentary conditioned reflex behavior in the rat following injection of 6-hydroxydopamine into the caudate nucleus and nucleus accumbens].
    Zhukova EM; Spiridonov VK
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(3):490-5. PubMed ID: 3092495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.